Preaddiction: A New Approach to Early Intervention in Substance Use Disorders
Engaging the public in screening and intervening with prediabetes has succeeded in halting progression for sud.
Imagine if we could identify and address substance use issues before they escalate. That's the intriguing idea behind 'preaddiction', a concept discussed in this episode of 'This Week in Addiction Medicine'. Drawing parallels to the successful early intervention strategies used for prediabetes, the hosts explore how similar methods could be applied to mild to moderate substance use disorders (SUD).
They discuss an opinion piece from JAMA Psychiatry that advocates for early screening and intervention to prevent the progression to severe SUD. Existing tools like brief interventions and computerized cognitive behavioral therapy are highlighted as potential game-changers. But it's not just about tools; the conversation also touches on the need for education in medical and nursing schools and proper reimbursement for these services. The hosts provide a well-rounded discussion, making it clear that a multifaceted approach is essential.
This episode doesn't stop at preaddiction. It also delves into various pressing topics in addiction medicine, including the relationship between cannabis use disorder and mental health issues like depression and anxiety, and innovative interventions for methamphetamine psychosis in emergency settings. The availability of critical medications like buprenorphine and naloxone in community pharmacies is another key point, along with the impact of hepatitis C treatment on those who inject drugs.
Ethical and legal considerations surrounding the use of psychedelics in brain wellness spas are also explored, as well as access to buprenorphine for physicians under state monitoring programs. Finally, the episode highlights a global shift towards a public health approach to substance use disorders. With expert commentary and engaging discussions, this episode offers valuable insights for anyone interested in the evolving field of addiction medicine.